Advertisement

Loading...

Statera Biopharma, Inc.

STAB•NASDAQ
Healthcare
Biotechnology
$0.00
$0.00(300.00%)
U.S. Market opens in 0h 57m

Statera Biopharma, Inc. (STAB) Stock Overview

Explore Statera Biopharma, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap28.6K
P/E Ratio-0.00
EPS (TTM)$-2.36
ROE66.77%
Fundamental Analysis

AI Price Forecasts

1 Month$0.00
3 Months$0.00
1 Year Target$0.03

STAB Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Statera Biopharma, Inc. (STAB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.53, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.03.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.00 and a market capitalization of 28.6K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
300.00%
5-Day Change
N/A
1-Month Change
300.00%
3-Month Change
33.33%
6-Month Change
300.00%
Year-to-Date (YTD) Change
33.33%
1-Year Change
300.000%
3-Year Change
-97.71%
5-Year Change
-99.99%
All-Time (Max) Change
-99.99%

Contact Information

https://www.staterabiopharma.com
888 613 8802
2537 Research Boulevard, Fort Collins, CO, 80526

Company Facts

460 Employees
IPO DateJul 28, 2021
CountryUS
Actively Trading

Frequently Asked Questions